Predictions
Orpea Nom.
Start price
Target price
Perf. (%)
€2.36
07.02.23
07.02.23
€4.00
07.02.24
07.02.24
9.32%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Innate Pharma
Start price
Target price
Perf. (%)
€3.24
10.02.22
10.02.22
€3.80
10.02.23
10.02.23
-4.81%
11.02.23
11.02.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€1.11
01.02.23
01.02.23
-
01.02.24
01.02.24
-0.36%
05.02.23
05.02.23
Risky Investment
Orpea Nom.
Start price
Target price
Perf. (%)
€5.54
01.02.23
01.02.23
-
01.02.24
01.02.24
-48.21%
05.02.23
05.02.23
Could be very worthwhile Investment >20% year
Sartorius Stedim Biotech S.A.
Start price
Target price
Perf. (%)
€335.80
16.10.22
16.10.22
-
16.10.23
16.10.23
2.74%
05.02.23
05.02.23
Euromedis Groupe
Start price
Target price
Perf. (%)
€10.64
24.12.21
24.12.21
-
24.12.22
24.12.22
-57.99%
25.12.22
25.12.22
Could be worthwhile Investment >10% per year